Explore
Validate
Learn22605-1-AP
antibody from Proteintech Group
Targeting: FNDC3B
DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22605-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- FNDC3B antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FNDC3B antibody (Cat. #22605-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Circular RNA circFNDC3B Modulates M2 Macrophage Activation and Intestinal Inflammation in Crohn's Disease.
Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach.
CircFndc3b Mediates Exercise-Induced Neuroprotection by Mitigating Microglial/Macrophage Pyroptosis via the ENO1/KLF2 Axis in Stroke Mice.
Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
CircRNA hsa_circ_0001627 aggravates cervical cancer progression through upregulation of FNDC3B and activating PI3K/mTOR signaling pathway.
Hirschsprung's disease: key microRNAs and target genes.
The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.
FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression.
Integrated Analysis of RNA-Binding Proteins in Glioma.
EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma.
FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.
Yin J, Liu M, Zhang L, Hu T, Yu Q, Kong R, Liu Z, Pang Z, Chen L, Zhou C, Ye Y
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Feb 28;40(4):e71498
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Feb 28;40(4):e71498
Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach.
van Leeuwen D, Cipullo M, Williams EC, Iannetta A, Chu B, Wang J, Hamza G, Crysnanto D, Guzzi N, Tan JY, Miele E, Sawarkar R, Mohorianu I, Prill S, Andersson P
NAR molecular medicine 2026 Apr;3(2):ugag016
NAR molecular medicine 2026 Apr;3(2):ugag016
CircFndc3b Mediates Exercise-Induced Neuroprotection by Mitigating Microglial/Macrophage Pyroptosis via the ENO1/KLF2 Axis in Stroke Mice.
Zhao Y, He X, Yang X, Hong Z, Xu Y, Xu J, Zheng H, Zhang L, Zuo Z, Hu X
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jan;12(1):e2403818
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Jan;12(1):e2403818
Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
Wang Y, Kong Y, Yang Q, Zhong C, Zhou D
European journal of medical research 2024 Apr 5;29(1):221
European journal of medical research 2024 Apr 5;29(1):221
CircRNA hsa_circ_0001627 aggravates cervical cancer progression through upregulation of FNDC3B and activating PI3K/mTOR signaling pathway.
Li Y, Meng F, Sui C, Wang Y, Cheng D
Journal of cell communication and signaling 2023 Sep;17(3):627-638
Journal of cell communication and signaling 2023 Sep;17(3):627-638
Hirschsprung's disease: key microRNAs and target genes.
Hong M, Li X, Li Y, Zhou Y, Li Y, Chi S, Cao G, Li S, Tang S
Pediatric research 2022 Sep;92(3):737-747
Pediatric research 2022 Sep;92(3):737-747
The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.
Sugrue E, Wickenhagen A, Mollentze N, Aziz MA, Sreenu VB, Truxa S, Tong L, da Silva Filipe A, Robertson DL, Hughes J, Rihn SJ, Wilson SJ
PLoS pathogens 2022 Nov;18(11):e1010973
PLoS pathogens 2022 Nov;18(11):e1010973
FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression.
Li YQ, Chen Y, Xu YF, He QM, Yang XJ, Li YQ, Hong XH, Huang SY, Tang LL, Liu N
Cancer science 2020 Jun;111(6):1991-2003
Cancer science 2020 Jun;111(6):1991-2003
Integrated Analysis of RNA-Binding Proteins in Glioma.
Wang Z, Tang W, Yuan J, Qiang B, Han W, Peng X
Cancers 2020 Apr 7;12(4)
Cancers 2020 Apr 7;12(4)
EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma.
Kong D, Ma W, Zhang D, Cui Q, Wang K, Tang J, Liu Z, Wu G
American journal of translational research 2019;11(4):2328-2338
American journal of translational research 2019;11(4):2328-2338
FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.
Hong Y, Qin H, Li Y, Zhang Y, Zhuang X, Liu L, Lu K, Li L, Deng X, Liu F, Shi S, Liu G
Journal of cellular physiology 2019 Nov;234(11):19895-19910
Journal of cellular physiology 2019 Nov;234(11):19895-19910
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FNDC3B antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FNDC3B. This antibody recognizes human, mouse, rat antigen. The FNDC3B antibody has been validated for the following applications: ELISA, WB analysis.
